Exchange Traded Concepts’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Exchange Traded Concepts’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,242	Closed	-$249K	–	1476
2023 Q4	$249K	Buy	4,242 +1,076	+34%	+$60.5K	0.01%	770
2023 Q3	$138K	Sell	3,166 -571	-15%	-$20.4K	﹤0.01%	830
2023 Q2	$135K	Buy	+3,737	New	+$154K	﹤0.01%	875
2022 Q1	–	Sell	-3,021	Closed	-$443K	–	1409
2021 Q4	$443K	Buy	+3,021	New	+$469K	0.01%	708
2021 Q2	–	Sell	-838	Closed	-$144K	–	1243
2021 Q1	$144K	Buy	838 +464	+124%	+$91.9K	0.01%	694
2020 Q4	$82K	Buy	+374	New	+$80.9K	﹤0.01%	688

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Exchange Traded Concepts's MRTX Position: Q1 2024 in Review

Exchange Traded Concepts sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 4,242 shares — an estimated $249K sold.

Exchange Traded Concepts first reported a position in MRTX in Q4 2020 and held it in 6 quarters. The position peaked at $443K in Q4 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Exchange Traded Concepts reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Exchange Traded Concepts sold 4,242 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $249K.
Exchange Traded Concepts first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Exchange Traded Concepts's Mirati Therapeutics, Inc. Common Stock position peaked at $443K in Q4 2021.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Exchange Traded Concepts's 13F filing for Q1 2024, filed 15 Apr 2024.